Cellular Dynamics International, Inc. announced that it has manufactured, under current Good Manufacturing Practices (cGMP), stem cell lines from two HLA "superdonors."...
Conroy is being recognized for leading Exact Sciences to being a significant force in the national fight against cancer....
Exact Sciences Corp. and Mayo Clinic today announced a five-year extension and expansion of their collaboration, broadening their efforts to develop screening, surveillance and diagnostic tests beyond colorectal cancer to address other diseases within the gastrointestinal tract....
A lot of times, when we think about tech businesses, we think about California and the Silicon Valley. But over the years, Madison has become a Midwestern hot spot for up-and-coming tech start ups....
University Research Park and UW-Madison continue to be significant catalysts for job creation in Wisconsin....
The Madison Startup Fair on University of Wisconsin-Madison’s campus brings together a cross-section of local startups each year, from software to 3D printing technology to alternative insulation material for outdoor gear....
Co-sponsored by the Capital Entrepreneurs and the Wisconsin Institutes for Discovery, the Madison Startup Fair showcased some of the best-known companies in the Madison startup space....
With its home test kit for colorectal cancer now available for use in the U.S. and Europe, Exact Sciences Corp. has become one of the fastest-growing businesses in the Madison area....
If you’re wondering how much of an impact the Madison area’s tech community has on the economy, take a gander at the year-end statistics and highlights of 2014 compiled by Capital Entrepreneurs....
In 2013, with 160 patents, the Wisconsin Alumni Research Foundation (WARF) was near the pinnacle of the university patent heap....
14 major Wisconsin companies will engage in a series of 15-minute meetings with emerging companies from across the state which apply for the chance to pitch their products, services and ideas at the Wisconsin Tech Summit....
Invenra has raised just over $2 million from investors that it will use to further develop its cell-free protein expression technology, a new SEC filing shows....